At CIRRUS, we apply our strengths to unlock
value and accelerate growth in a challenging investment environment. We seek opportunities and investments
that take advantage of unique inflection points, where return potentials are high and risks are managed.
Our values and commitment set us apart. Above all, we serve
the needs of our investors and clients with integrity, excellence and accountability. CIRRUS' operations
are marked by prudence and financial discipline.
These attributes, combined with a deep passion to
succeed, together exemplify CIRRUS Capital Partners.
CIRRUS
Capital Partners was founded in 2009 and is headquartered in Austin, Texas.
Sector Overview
Overall,
Americans use more medicines than people in other developed countries. They rank first
for the use of antipsychotics, as well as drugs for dementia, respiratory problems and rheumatoid arthritis.
The three largest U.S. pharmaceutical companies generated over $120
billion in revenue in 2013, while Americans filled an estimated 4 billion in prescriptions.
These manufacturers, distributors and sellers are responsible for delivering safe products and consumers assume that prescription
drugs and medical devices have been thoroughly tested before being sold. Unfortunately that is not always the case.
All too often, serious side effects show up months or even years after a drug is introduced. Approximately 1.5
million pharmaceutical-related injuries occur each year, at a cost of $4 billion.
Sources: Am J
Health-Syst. Pharm-Vol. 71, 2014, Drugwatch.com
